샘플 요청 목록

 카트 문의
시장보고서
상품코드
1766919

세계의 생물학적 데이터 시각화 시장

Biological Data Visualization
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 381 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생물학적 데이터 시각화 세계 시장은 2030년까지 21억 달러에 달할 전망

2024년에 13억 달러로 추정되는 생물학적 데이터 시각화 세계 시장은 2024년부터 2030년까지 CAGR 7.8%로 성장하여 2030년에는 21억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석되고 있는 부문 중 하나인 시퀀싱은 CAGR 7.9%를 기록하며 분석 기간 종료시에는 8억 1,450만 달러에 달할 것으로 예측됩니다. 현미경 분야의 성장률은 분석 기간 동안 CAGR 7.8%로 추정됩니다.

미국 시장은 3억 4,320만 달러로 추정, 중국은 CAGR 11.9%로 성장 예측

미국의 생물학적 데이터 시각화 시장은 2024년에는 3억 4,320만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년 분석 기간 동안 CAGR 11.9%로 성장하여 2030년에는 5억 3,660만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 3.4%와 6.7%로 예측됩니다. 유럽에서는 독일이 CAGR 4.3%로 성장할 것으로 예측됩니다.

세계 생물학적 데이터 시각화 시장 - 주요 동향 및 촉진요인 정리

기술 혁신은 생물학적 데이터 시각화를 어떻게 변화시킬 것인가?

데이터 분석 및 시각화 도구의 기술 발전은 생물학적 데이터 시각화 시장에 혁명을 가져왔으며, 연구자들은 복잡한 데이터세트를 보다 정확하고 빠르게 해석할 수 있게 되었습니다. 생물학적 데이터 시각화는 유전자 서열, 단백질 구조, 분자간 상호작용 등 생물학적 데이터를 그래픽으로 표현하여 생물학적 과정과 질병 메커니즘에 대한 이해를 돕습니다. 최근 빅데이터 분석, 인공지능(AI), 머신러닝(ML) 분야의 기술 혁신은 대량의 생물학적 데이터를 처리하고 의미 있는 시각적 인사이트를 창출하는 능력을 향상시키고 있습니다. 고성능 컴퓨팅(HPC) 플랫폼과 클라우드 기반 시각화 도구는 생물학적 데이터 분석의 접근성과 확장성을 더욱 향상시켜 연구자들이 전 세계 프로젝트에서 실시간으로 협업할 수 있도록 돕고 있습니다. 데이터 시각화 소프트웨어에 AI 기반 알고리즘이 통합되어 자동 패턴 인식 및 예측 모델링이 가능해짐에 따라 연구자들은 중요한 생물학적 동향과 관계를 보다 빠르게 파악할 수 있게 되었습니다. 이러한 발전은 과학자들이 생물학적 데이터를 분석하는 방식을 변화시켜 보다 정확하고 효율적인 신약 개발, 유전체 연구, 맞춤형 의료에 대한 노력을 촉진하고 있습니다.

생물학적 데이터 시각화가 생명과학에 필수적인 이유는 무엇일까?

최신 연구 기술로 인해 데이터의 양과 복잡성이 기하급수적으로 증가하고 있는 생명과학 분야에서 생물학적 데이터 시각화는 점점 더 필수적인 요소로 자리 잡고 있습니다. 유전체학, 단백질체학, 대사체학 연구 및 신약개발 연구에서는 방대한 양의 데이터가 생성되지만, 의미 있는 인사이트를 얻기 위해서는 고도의 시각화 기술이 필요합니다. 복잡한 생물학적 데이터를 그래픽 형식으로 표현함으로써 연구자들은 시각화 도구를 통해 원시 데이터만으로는 발견하기 어려운 패턴, 관계, 이상을 식별할 수 있습니다. 이는 유전자 서열을 매핑하고 비교하는 데 시각적 도구가 사용되는 유전체학이나 단백질의 구조와 상호작용을 시각화할 수 있는 단백질체학 분야에서 특히 중요합니다. 또한, 생물학적 데이터의 시각화는 맞춤형 의료의 발전에도 중요한 역할을 하고 있습니다. 개별 유전자 프로파일에 맞는 치료를 하기 위해서는 환자별 데이터를 분석해야 합니다. 생명과학 분야의 발전과 함께 생물학적 데이터 시각화는 새로운 발견을 이끌어내고 과학의 진보를 가속화하는 데 필수적인 요소로 자리 잡고 있습니다.

산업과 헬스케어의 동향은 생물학적 데이터 시각화 시장을 어떻게 형성하고 있는가?

생물학적 데이터 시각화 시장은 헬스케어 및 생명과학 산업의 몇 가지 주요 트렌드, 특히 맞춤형 의료에 대한 관심 증가와 멀티오믹스 연구의 부상으로 인해 형성되고 있습니다. 맞춤형 의료가 계속 확산됨에 따라 정교한 데이터 시각화 도구의 필요성이 대두되고 있습니다. 연구 개발자와 임상의는 유전체 서열, 단백질체학 프로파일, 임상 기록 등 대규모의 복잡한 데이터세트를 분석하여 고유한 바이오마커를 식별하고, 환자 개개인에 맞는 맞춤형 치료법을 개발해야 합니다. 이러한 데이터 기반 맞춤형 의료로의 전환은 환자별 데이터를 처리하고 해석할 수 있는 고급 생물학적 데이터 시각화 솔루션에 대한 수요를 촉진하고 있습니다. 또한, 유전체학, 단백질체학, 전사체학, 대사체학 등의 데이터를 통합하는 멀티오믹스 접근법의 채택이 확대되면서 생물학적 데이터 분석의 복잡성이 더욱 커지고 있습니다. 이러한 다층적인 데이터세트를 일관되고 해석 가능한 방식으로 통합하고 표시할 수 있는 시각화 도구는 연구 발전과 임상 결과 개선에 필수적인 요소로 자리 잡고 있습니다.

생물학적 데이터 시각화 시장의 성장을 촉진하는 요인은 무엇일까?

생물학적 데이터 시각화 시장의 성장은 생물학적 연구의 복잡성, 데이터 분석의 기술적 진보, 맞춤형 의료의 역할 확대 등 여러 요인에 의해 이루어지고 있습니다. 주요 요인 중 하나는 유전체 및 멀티오믹스 연구의 급격한 성장으로 분석에 고급 시각화 도구가 필요한 방대한 양의 데이터가 생성되고 있으며, AI와 머신러닝의 부상도 시장 성장에 기여하고 있습니다. 이러한 기술은 데이터 분석과 패턴 인식의 자동화를 가능하게 하고, 연구자들이 복잡한 생물학적 데이터에서 인사이트를 쉽게 도출할 수 있도록 도와주기 때문입니다. 또한, 맞춤형 의료에 대한 관심이 높아지면서 임상의가 환자별 데이터를 해석하고 맞춤형 치료 계획을 수립하는 데 도움이 되는 시각화 도구에 대한 수요가 증가하고 있습니다. 클라우드 컴퓨팅과 고성능 컴퓨팅 플랫폼의 확장은 생물학적 데이터 시각화 솔루션의 접근성과 확장성을 더욱 향상시켜 연구자들이 대규모 프로젝트에서 공동 작업하고 전 세계적으로 연구 결과를 공유할 수 있도록 돕고 있습니다. 수 있도록 지원합니다. 데이터 기반 연구와 개인화된 헬스케어에 대한 수요가 지속적으로 증가함에 따라 생물학적 데이터 시각화 시장은 지속적으로 성장할 것으로 예상됩니다.

부문

기술(시퀀싱, 현미경, 자기공명영상, X선 결정구조 분석, 기타 기술), 용도(세포·생물 이미징, 구조 생물학·분자 모델링, 유전체 해석, 얼라인먼트, 계통·진화, 시스템 생물학), 최종 용도(학술 연구, 제약·바이오테크놀러지 기업, 병원·클리닉, 기타 최종 용도)

조사 대상 기업 사례

  • 3M
  • Advanced Visual Systems, Inc.
  • Agilent Technologies
  • arivis AG
  • Becton, Dickinson and Company(BD)
  • Carl Zeiss AG
  • Clarivate Analytics
  • Danaher
  • Genedata AG
  • Genialis, Inc.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.07.16

Global Biological Data Visualization Market to Reach US$2.1 Billion by 2030

The global market for Biological Data Visualization estimated at US$1.3 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Sequencing, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$814.5 Million by the end of the analysis period. Growth in the Microscopy segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$343.2 Million While China is Forecast to Grow at 11.9% CAGR

The Biological Data Visualization market in the U.S. is estimated at US$343.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$536.6 Million by the year 2030 trailing a CAGR of 11.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Biological Data Visualization Market - Key Trends & Drivers Summarized

How Are Technological Innovations Transforming Biological Data Visualization?

Technological advancements in data analytics and visualization tools are revolutionizing the biological data visualization market, enabling researchers to interpret complex datasets with greater precision and speed. Biological data visualization involves the graphical representation of biological data, such as genetic sequences, protein structures, and molecular interactions, to enhance the understanding of biological processes and disease mechanisms. Recent innovations in big data analytics, artificial intelligence (AI), and machine learning (ML) are improving the ability to process large volumes of biological data and generate meaningful visual insights. High-performance computing (HPC) platforms and cloud-based visualization tools are further enhancing the accessibility and scalability of biological data analysis, allowing researchers to collaborate on global projects in real time. The integration of AI-driven algorithms in data visualization software is enabling automated pattern recognition and predictive modeling, helping researchers identify critical biological trends and relationships faster. These advancements are transforming the way scientists analyze biological data, facilitating more accurate and efficient drug discovery, genomics research, and personalized medicine initiatives.

Why Is Biological Data Visualization Becoming Essential in Life Sciences?

Biological data visualization is becoming increasingly essential in the life sciences, where the volume and complexity of data generated by modern research techniques are growing exponentially. Genomics, proteomics, and metabolomics research, as well as drug discovery, generate vast amounts of data that require sophisticated visualization techniques to uncover meaningful insights. By representing complex biological data in a graphical format, visualization tools enable researchers to identify patterns, relationships, and anomalies that would be difficult to detect through raw data alone. This is particularly important in genomics, where visual tools are used to map and compare genetic sequences, and in proteomics, where researchers can visualize protein structures and interactions. Additionally, biological data visualization is playing a critical role in the development of personalized medicine, where patient-specific data must be analyzed to tailor treatments to individual genetic profiles. As the life sciences field continues to advance, biological data visualization is becoming indispensable for unlocking new discoveries and accelerating scientific progress.

How Are Industry and Healthcare Trends Shaping the Biological Data Visualization Market?

The biological data visualization market is being shaped by several key trends in the healthcare and life sciences industries, particularly the increasing focus on personalized medicine and the rise of multi-omics research. As personalized medicine continues to gain traction, the need for sophisticated data visualization tools is becoming more pronounced. Researchers and clinicians must analyze large, complex datasets-such as genomic sequences, proteomic profiles, and clinical records-to identify unique biomarkers and develop tailored therapies for individual patients. This shift toward data-driven, personalized healthcare is driving demand for advanced biological data visualization solutions that can handle and interpret patient-specific data. Moreover, the growing adoption of multi-omics approaches, which integrate data from genomics, proteomics, transcriptomics, and metabolomics, is further increasing the complexity of biological data analysis. Visualization tools that can synthesize and display these multi-layered datasets in a coherent and interpretable manner are becoming critical for advancing research and improving clinical outcomes.

What Factors Are Driving Growth in the Biological Data Visualization Market?

The growth in the biological data visualization market is driven by several factors, including the increasing complexity of biological research, technological advancements in data analytics, and the expanding role of personalized medicine. One of the primary drivers is the rapid growth of genomics and multi-omics research, which generates vast amounts of data that require sophisticated visualization tools to analyze. The rise of AI and machine learning is also contributing to market growth, as these technologies enable the automation of data analysis and pattern recognition, making it easier for researchers to derive insights from complex biological data. Additionally, the growing focus on personalized medicine is driving demand for visualization tools that can help clinicians interpret patient-specific data and develop tailored treatment plans. The expansion of cloud computing and high-performance computing platforms is further enhancing the accessibility and scalability of biological data visualization solutions, enabling researchers to collaborate on large-scale projects and share insights globally. As the demand for data-driven research and personalized healthcare continues to rise, the biological data visualization market is expected to experience sustained growth.

SCOPE OF STUDY:

The report analyzes the Biological Data Visualization market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technique (Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography, Other Techniques); Application (Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis, Alignments, Phylogeny & Evolution, Systems Biology); End-Use (Academic Research, Pharma & Biotech Companies, Hospitals & Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

  • 3M
  • Advanced Visual Systems, Inc.
  • Agilent Technologies
  • arivis AG
  • Becton, Dickinson and Company (BD)
  • Carl Zeiss AG
  • Clarivate Analytics
  • Danaher
  • Genedata AG
  • Genialis, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Biological Data Visualization - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Volume of Genomic and Proteomic Data Drives Growth in the Biological Data Visualization Market
    • Technological Advancements in Data Analytics Propel the Use of Visualization Tools in Life Sciences
    • Increasing Adoption of Big Data in Healthcare and Biotechnology Expands Market for Biological Data Visualization
    • Growing Focus on Precision Medicine Fuels Demand for Advanced Visualization Tools in Genomic Research
    • Technological Innovations in 3D and Virtual Reality (VR) Visualization Enhance Interpretation of Complex Biological Data
    • Rising Use of Artificial Intelligence (AI) and Machine Learning (ML) in Biological Data Visualization Expands Capabilities
    • Growing Integration of Cloud Computing and Visualization Software Strengthens Market for Real-Time Data Analysis
    • Increased Adoption of Biological Data Visualization Tools in Drug Discovery and Development Expands Market Scope
    • Technological Developments in Multi-Omics Data Integration Drive Demand for Advanced Visualization Platforms
    • Rising Focus on Collaborative Research and Data Sharing Expands Use of Cloud-Based Visualization Tools in Life Sciences
    • Growing Use of Biological Data Visualization in Clinical Research and Trials Expands Opportunities for Personalized Medicine
    • Increased Adoption of Biological Data Visualization in Agricultural Genomics and Crop Improvement Expands Market
    • Technological Integration of Augmented Reality (AR) with Biological Data Visualization Tools Enhances Research Insights
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Biological Data Visualization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Biological Data Visualization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Biological Data Visualization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Microscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Magnetic Resonance Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for X-ray Crystallography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for X-ray Crystallography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for X-ray Crystallography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Systems Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Systems Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Systems Biology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Cell & Organism Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Cell & Organism Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Cell & Organism Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Structural Biology & Molecular Modeling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Structural Biology & Molecular Modeling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Structural Biology & Molecular Modeling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Genomic Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Genomic Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Genomic Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Alignments, Phylogeny & Evolution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Alignments, Phylogeny & Evolution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Alignments, Phylogeny & Evolution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 39: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 42: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 43: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 44: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 45: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 46: World Biological Data Visualization Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Biological Data Visualization by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Biological Data Visualization by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Biological Data Visualization by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 122: UK Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: UK 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Spain 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 137: Spain Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Spain Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Spain 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Russia 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 146: Russia Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Russia Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Russia 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Biological Data Visualization by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Biological Data Visualization by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Australia 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 176: Australia Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Australia Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Australia 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 179: India Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: India 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 185: India Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: India Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: India 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: South Korea 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 194: South Korea Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: South Korea Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: South Korea 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Asia-Pacific Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Biological Data Visualization by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Biological Data Visualization by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Latin America 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 215: Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Latin America Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Latin America 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Argentina 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 224: Argentina Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Argentina Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Argentina 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Brazil 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 233: Brazil Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Brazil Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Brazil 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Mexico 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 242: Mexico Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Mexico Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Mexico 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Latin America Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Latin America 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Biological Data Visualization by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Biological Data Visualization by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Middle East 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 263: Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Middle East Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Middle East 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Iran 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 272: Iran Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Iran Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Iran 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Israel 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 281: Israel Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Israel Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Israel 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Saudi Arabia Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Saudi Arabia 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: UAE 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 299: UAE Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: UAE Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: UAE 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Middle East Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Middle East 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Africa 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
    • TABLE 317: Africa Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Africa Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Africa 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제